BIOTRONIK Launches Smallest MR Conditional Pacing Lead Available in the United States

Nearly 600,000 Solia Family Leads Implanted Worldwide since 2009

LAKE OSWEGO, Oregon, June 16, 2016 – BIOTRONIK announced today the commercial launch of Solia S ProMRI®, with a 5.6 French lead body, the smallest MR conditional pacing lead available in the United States. Solia S ProMRI is available in 45, 53 and 60 centimeter lengths.

Solia received Food and Drug Administration (FDA) approval on June 9, 2016 based on data collected during the Pre-Market Study (IDE) phase of the SIELLO clinical study.

  1. Investigational Device: Limited by US law to investigational use.


BIOTRONIK is a leading medical device company that has been developing trusted and innovative cardiovascular and endovascular solutions for more than 50 years. Driven by a purpose to perfectly match technology with the human body, BIOTRONIK innovations deliver care that saves and improves the lives of millions diagnosed with heart and blood vessel diseases every year. BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries.